Joseph Hernandez's Net Worth
$7.81 Million
Who is Joseph Hernandez?
Joseph Hernandez has an estimated net worth of $7.81 Million. This is based on reported shares across multiple companies, which include Microlin Bio, Inc, CLARUS THERAPEUTICS INC, Blue Water Vaccines Inc., ORAGENICS INC, Clarus Therapeutics Holdings, Inc., and SYDYS CORP.
SEC CIK
Joseph Hernandez's CIK is 0001598384
Past Insider Trading and Trends
2022 was Joseph Hernandez's most active year for acquiring shares with 5 total transactions. Joseph Hernandez's most active month to acquire stocks was the month of March. 2021 was Joseph Hernandez's most active year for disposing of shares, totalling 8 transactions. Joseph Hernandez's most active month to dispose stocks was the month of December. 2022 saw Joseph Hernandez paying a total of $3,445,000.00 for 4,889,227 shares, this is the most they've acquired in one year. In 2022 Joseph Hernandez cashed out on 549,649 shares for a total of $2,640,692.79, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Microlin Bio, Inc No price found
CEO, CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CLARUS THERAPEUTICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.3M |
—
|
—
| 1.3M |
Sep 9
| |||
| No matching records found | |||||||||
Blue Water Biotech, Inc. (BWV) No price found
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.66% | 150K |
—
|
—
| 2.8M |
May 9
| |||
Form 4
| -17.18% | -549.65K |
$4.80 | -$2,640,692.79 | 2.65M |
Aug 18 - Aug 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ORAGENICS INC (OGEN) Snapshot price: $0.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.20M |
$0.74 | -$3,117,289.08 |
0
|
Jan 4 - Jan 14
| |||
Form 4
| -54.35% | -5.00M |
$0.41 | -$2,051,500.00 | 4.2M |
Dec 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Clarus Therapeutics Holdings, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.15% | 1.92K |
—
|
—
| 1.24M |
Jun 7
| |||
Form 4
| +89.75% | 1.17M |
—
|
—
| 2.48M |
Apr 25
| |||
Form 4
|
∞
| 3.84K |
—
|
—
| 3.84K |
Dec 12
| |||
Form 4/A
|
∞
| 1.3M |
—
|
—
| 1.3M |
Sep 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||